MAGE-A3 cancer therapeutic Trojan peptide vaccine

MAGE-A3 cancer therapeutic Trojan peptide vaccine
Trade Name
Orphan Indication Squamous cell carcinoma of head and neck
USA Market Approval USA
USA Designation Date 2008-11-24 00:00:00
Sponsor Gliknik, Inc.;801 W. Baltimore Street, Suite 501A;Baltimore, Maryland, 21201